1. Clinical Pharmacokinetics and Impact of Hematocrit on Monitoring and Dosing of Tacrolimus Early After Heart and Lung Transplantation

   • Maaike A. Sikma
   • Claudine C. Hunault
   • Erik M. Van Maarseveen

   Current Opinion Open access 10 December 2019 Pages: 403 - 408

   

2. Omadacycline: A Review of the Clinical Pharmacokinetics and Pharmacodynamics

   • Keith A. Rodvold
   • Rodrigo M. Burgos
   • Manjunath P. Pai

   Review Article 27 November 2019 Pages: 409 - 425

   

3. Therapeutic Drug Monitoring of Antiepileptic Drugs in Women with Epilepsy Before, During, and After Pregnancy

   • Inge J. Arfman
   • Elisabeth A. Wammes-van der Heijden
   • Daan J. Touw

   Review Article 08 January 2020 Pages: 427 - 445

   

4. A Systematic Review of Gastric Acid-Reducing Agent-Mediated Drug–Drug Interactions with Orally Administered Medications

   • Divya Patel
   • Richard Bertz
   • Mats Någård

   Review Article Open access 02 December 2019 Pages: 447 - 462

   

5. Population Pharmacokinetics of Blinatumomab in Pediatric and Adult Patients with Hematological Malignancies

   • John David Clements
   • Min Zhu
   • Sameer Doshi

   Original Research Article Open access 02 November 2019 Pages: 463 - 474

   

6. Evaluating the Relationship Between Lean Liver Volume and Fat-Free Mass

   • Jaydeep Sinha
   • Stephen B. Duffull
   • Hesham S. Al-Sallami

   Original Research Article 04 October 2019 Pages: 475 - 483

   

7. A Preterm Physiologically Based Pharmacokinetic Model. Part I: Physiological Parameters and Model Building

   • Khaled Abduljalil
   • Xian Pan
   • Trevor N. Johnson

   Original Research Article 04 October 2019 Pages: 485 - 500

   

8. Preterm Physiologically Based Pharmacokinetic Model. Part II: Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population

   • Khaled Abduljalil
   • Xian Pan
   • Trevor N. Johnson

   Original Research Article 05 October 2019 Pages: 501 - 518

   

9. Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial Revisited

   • Amina Bensalem
   • Denis Mulleman
   • David Ternant

   Original Research Article 05 October 2019 Pages: 519 - 530